NEW YORK (GenomeWeb news) – Pacific Biosciences has raised $68 million in a round of financing from new and previous investors, bringing the total amount it has raised since the summer of 2008 to $188 million, the company said today.

The DNA sequencing technology developer plans to launch a commercial version of its single-molecule, real-time (SMRT) Sequencing System in the second half of 2010.

New investors joining this round of funding include the Wellcome Trust, Monsanto, and Sutter Hill Ventures.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.

Sponsored by
Thermo Fisher Scientific

In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, will discuss her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.